Laura Dillon

Company: Parthenon Therapeutics
Job title: Head of Translational Biomarkers
Seminars:
Characterization of Immune Excluded Tumors by Multiplex Immunofluorescence for Precision Oncology applications 11:00 am
• Understanding how the spatial relationship between immune cells and the tumor epithelium vs tumor associated stroma is key to reviewing immune exclusion and its relationship to CPI therapy resistance • Thoughtful mIF panel design and reagent validation are necessary to enable interpretation of mIF output • Novel methods are needed to better characterize the…Read more
day: Conference Agenda